Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: An overview

Yonsei Medical Journal

Volumn 48, Issue 6, 2007, Pages 901-926

  Atanassova, Penka A ^a  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Classifications; Criteria; Etio pathogenesis; Ischemic; Neurological; Occlusive

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYTOKINE; DROTRECOGIN; FRESH FROZEN PLASMA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; RITUXIMAB; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CHOREA; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; FETUS WASTAGE; HUMAN; IMMUNOASSAY; INTERNATIONAL NORMALIZED RATIO; ISCHEMIA; KIDNEY DISEASE; LOW DRUG DOSE; MATERNAL MORTALITY; MENTAL DISEASE; NEUROLOGIC DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLASMAPHERESIS; PREGNANCY DISORDER; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS; VASCULAR DISEASE; VEIN THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ARTERIAL OCCLUSIVE DISEASES; CEREBROVASCULAR DISORDERS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 38049177510     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.6.901     Document Type: Review

References (211)

1. Hughes GR. The anticardiolipin syndrome. Clin Exp Rheumatol 1985;3:285-6.
2. Alarcón-Segovia D, Delezé M, Oria CV, Sánchez-Guerrero J, Gómez-Pacheco L, Cabiedes J, et al. Anti-phospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68:353-65.
3. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366-74.
4. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
5. Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000;43:440-3.
6. Pierangeli SS, Gharavi AE, Harris EN. Anticardiolipin testing. In: Khamashta MA, editor. Hughes syndrome. London: Springer, 2000. p-205-13.
7. Mackie IJ, Donohoe S, Machin SJ. Lupus anticoagulant measurement. In: Khamashta MA, editor. Hughes' syndrome. London: Springer; 2000. p.214-24.
8. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation. Committee of the ISTH. Thromb Haemost 1995;74-1185-90.
9. Roubey RAS. Antiphospholipid antibody-negative syndrome-other phospholipids. In: Khamashta MA, editor. Hughes' syndrome. London: Springer; 2000. p.253-60.
10. Lee RM, Emlen W, Scott JR, Branch DW, Silver RM. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Am J Obstet Gynecol 1999;181:642-8.
11. Rand JH. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 2002;90:29-37.
12. Giannakopoulos B, Passam F, Rahgozar S, Krilis SA, Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007;109:422-30.
13. Sherer Y, Berkun Y, Blank M, Shoenfeld Y. Pathogenesis of the antiphospholipid syndrome. Pediatr Rheumatol Online J 2004;2:492-6.
14. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006;65:2-6.
15. Kochenour NK, Branch DW, Rote NS, Scott JR. A New postpartum syndrome associated with antiphospholipid antibodies. Obstet Gynecol 1987;69:460-8.
16. Kupferminc MJ, Lee MJ, Green D, Peaceman AM. Severe postpartum pulmonary, cardiac and renal syndrome associated with antiphospholipid antibodies. Obstet Gynecol 1994;83:806-7.
17. Cervera R, Asherson RA, Font J, Tikly M, Pallarés L, Chamorro A, et al, Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 1997;76:203-12.
18. Lê Thi Huong D, Wechsler B, Edelman P, Fournié A, Le Tallec Y, Piette JC, et al. Postpartum cerebral infarction associated with aspirin withdrawal in the antiphospholipid antibody syndrome. J Rheumatol 1993;20:1229-32.
19. Hochfeld M, Druzin ML, Maia D, Wright J, Lambert RE, McGuire J. Pregnancy complicated by primary antiphospholipid antibody syndrome. Obstet Gynecol 1994;83:804-5.
20. Ornstein MH, Rand JH. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: a report of 2 cases. J Rheumatol 1994;21:1360-4.
21. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-27.
22. Asherson RA, Cervera R, Piette JC, Shoenfeld Y. Milestones in the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, editors. The antiphospholipid sysdrome. II. Autoimmune thrombosis. Amsterdam: Elsevier; 2002. p.3-9.
23. Bruce D, Bateman D, Thomas R. Left ventricular thrombi in a patient with the antiphospholipid syndrome. Br Heart J 1995;74-202-3.
24. O'Neill D, Magaldi J, Dobkins D, Greco T. Dissolution of intracardiac mass lesions in the primary antiphospholipid antibody syndrome, Arch Intern Med 1995;155:325-7.
25. Nickele GA, Foster PA, Kenny D. Primary antiphospholipid syndrome and mitral valve thrombosis. Am Heart J 1994;128:1245-7.
26. Murphy JJ, Leach IH. Fidings of necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J 1989;62-61-4.
27. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411-9.
28. Hasnie AM, Stoddard MF, Gleason CB, Wagner SG, Longaker RA, Pierangeli S, et al. Diastolic dysfunction is a feature of the antiphospholipid syndrome. Am Heart J 1995;129:1009-13.
29. Martinez-Levin M, Fonseca C, Amigo MC, Nava A, Reyes PA, Ruiz-Arguelles A. Antiphospholipid syndrome in patients with cyanotic congenital heart disease. Clin Exp Rheumatol 1995;13:489-91.
30. Donaldson MC, Weinberg DS, Belkin M, Whittemore AD, Mannick JA. Screening for hypercoagulable states in vascular surgical practice: A preliminary study. J Vasc Surg 1990;11:825-31.
31. Shortell CK, Ouriel K, Green RM, Condemi JJ, DeWeese JA. Vascular disease in the antiphospholipid syndrome: a comparison with the patient population with atherosclerosis. J Vasc Surg 1992;15:158-66.
32. Taylor LM, Chitwood RW, Dalman RL, Sexton G, Goodnight SH, Porter JM. Antiphospholipid antibodies in vascular surgery patients. A cross-sectional study. Ann Surg 1994;220:545-51.
33. Liote F, Meyer O, Osteoarticular manifestations in the antiphospholipid syndrome. In: Asherson R A, Cervera. R, Piette J-C, Shoenfeld Y, editors. The Antiphospholipid Syndrome. Boca Raton: CRC Press; 1996. p.195-200.
34. Asherson RA, Liote F, Page B, Meyer O, Buchanan N, Khamashta MA, et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993;20:284-8.
35. Nagasawa K, Ishii Y, Mayumi T, Tada Y, Ueda A, Yamauchi Y, et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 1989;48:672-6.
36. Kleiner RC, Najarian LV, Schatten S, Jabs DA, Patz A, Kaplan HJ. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 1989;96:896-904.
37. Dessein PH, Lamparelli RD, Phillips SA, Rubenchik IA, Zwi S. Severe immune thrombocytopenia and the development of skin infarctions in a patient with an overlap syndrome. J Rheumatol 1989;16:1494-6.
38. Aronoff DM, Callen JP. Necrosing livedo reticularis in a patient with recurrent pulmonary hemorrhage. J Am Acad Dermatol 1997;37:300-2.
39. Del Castillo LF, Soria C, Schoendorff C, Garcia Garcia C, Diaz-Caballero N, Rodriguez Alen A, et al. Widespread cutaneous necrosis and antiphospholipid antibodies: Two episodes related to surgical manipulation and urinary tract infection. J Am Acad Dermatol 1997;36:872-5.
40. Amster MS, Conway J, Zeid M, Pincus S. Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus. J Am Acad Dermatol 1993;29:853-7.
41. Wolf P, Soyer HP, Auer-Grumbach P, Kerl H. Widespread cutaneous necrosis in a patient with rheumatoid arthritis associated with anticardiolipin antibodies. Arch Dermatol 1991;127.1739-40.
42. Hill VA, Whittaker SJ, Hunt BJ, Liddell K, Spittle MF, Smith NP. Cutaneous necrosis associated with the antiphospholipid syndome and mycosis fungoides. Br J Dermatol 1994;130:92-6.
43. Liano F, Mampaso F, Garcia Martin F, Pardo A, Orte L, Teruel JL. Allograft membranous glomerulonephritis and renal-vein thrombosis in a patient with a lupus anticoagulation factor. Nephrol Dial Transplant 1988; 3:684-9.
44. Grob JJ, Bonerandi JJ. Cutaneous manifestations associated with the presence of the lupus anticoagulant. A report of two cases and a review of the literature. J Am Acad Dermatol 1986;15:211-9.
45. Asherson RA, Jacobelli S, Rosenberg H, Mckee p, Hughes GR. Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome - a report of two cases. Clin Exp Dermatol 1992;17-266-9.
46. Asherson RA. Subungual splinter haemorrhages: a new sign of the antiphospholipid coagulopathy? Ann Rheum Dis 1990;49:268.
47. Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varner MW, Baringer JR. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 1989;25:228-32.
48. Fawcett RS, Linford S, Stulberg DL. Nail abnormalities: clues to systemic disease. Am Fam Physician 2004; 69:1417-24.
49. Ruffatti A, Veller-Fornasa C, Patrassi GM, Sartori E, Tonello M, Tonetto S, et al. Anticardiolipin antibodies and antiphospholipid syndrome in chronic discoid lupus erythematosus. Clin Rheumatol 1995;14:402-4.
50. Alarcón-Segovia D, Pérez-Vázquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome with systemic lupus erythematosus. Semin Arthritis Rheum 1992;21:275-86.
51. Atanassova PA, Dimitrov BD. Neurological and systemic disorders in antiphospholipid syndrome: novel constellations on a genetic basis. Clin Neurol Neurosurg 2006;108:814.
52. Luchi ME, Asherson RA, Lahita RG. Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. Arthritis Rheum 1992;35:700-5.
53. Brucato A, Baudo F, Barberis M, Redaelli R, Casadeo G, Allegri F, et al. Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome. Rheumatol 1994;21:942-4.
54. Weiss L, Dimitrov DS, Angelova M. The hemodynamic destruction of intravascular cancer cells in relation to myocardial metastasis. Proc Natl Acad Sci U S A 1985;82:5737-41.
55. Kerr JE, Poe R, Kramer Z. Antiphospholipid antibody syndrome presenting as a refractory non-inflammatory pulmonary vasculopathy. Chest 1997;112:1707-10.
56. Crausman RS, Achenbach GA, Pluss WT, O'Brien RF, Jennings CA. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol 1995;22:554-6.
57. Asherson RA, Greenblatt MA. Recurrent alveolar haemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome. J Clin Rheumatol 2001;7: 30-3.
58. Savin H, Huberman M, Kott E, Lishner M, Kitai Y, Kidron D, et al. Fibrosing alveolitis associated with primary antiphospholipid syndrome. Br J Rheumatol 1994;33:977-80.
59. Asherson RA, Kant KS. Antiphospholipid antibodies and the kidney. J Rheumatol 1993;20:1268-72.
60. Piette J-C, Kleinknecht D, Bach J-F. Renal manifestations in the antiphospholipid syndrome. In: The Antiphospholipid Syndrome. Asherson RA, Cervera R, Piette J-C, Shoenfeld Y (editrs). New York: CRC Press. Boca Raton; 1996. p.169-81.
61. Frampton G, Hicks J, Cameron JS. Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int 1991;39:1225-31.
62. Glueck HI, Kant KS, Weiss MA, Pollak VE, Miller MA, Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985;145:1389-95.
63. Bhathena DB, Sobel BJ, Migdal SD. Noninflammatory renal microangiopathy of systemic lupus erythematosus ("lupus vasculitis"). Am J Nephrol 1981;1:144-59.
64. Churg J, Goldstein MH, Bernstein J. Thrombotic angiopathy including haemolytic-uremic syndrome, thrombotic thrombocytopenic purpura and postpartum renal failure. In: Renal Pathology with Clinical and Functional Correlates. Tister CC, Brenner BM, editors. Vol 2. Philadelphia: J B Lippincott; 1989. p.1081-113.
65. Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min KW, Silva T. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 1992;20: 150-8
66. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-12.
67. Rao RH, Vagnucci AH, Amico JA. Bilateral massive adrenal hemorrhage: early recognition and treatment. Ann Intern Med 1989;110:227-35.
68. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335:1206-12.
69. Blanc PL, Forel C, Jay S, Susset V. Acute adrenal insufficiency during unilateral adrenal hemorrhage secondary to the antiphosphohpid syndrome. Rev Med Interne 2006;27:970-2.
70. Valla D, Benhamou JP. Disorders of the hepatic veins and venules. In: Oxford Textbook of Clinical Hepatology (editors) McIntyre N, Benhamou JP, Bircher J, Rizetto M, Rodes J. Oxford University Press; 1991. p.1004-11.
71. Ouwendijk RJ, Koster JC, Wilson JH, Stibbe J, Lameris JS, Visser W, et al. Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatment. Gut 1994;35:1004-6.
72. De Clerck LS, Michielsen PP, Ramael MR, Janssens E, Van Maercke YM, Van Marck EA, et al. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. J Rheumatol 1991;18:1919-21.
73. Takahaski C, Kumagai S, Tsubata R, Sorachi K, Ozaki S, Imura H, et al. Portal hypertension associated with anticardiolipin antibodies in a case of systemic lupus erythematosus. Lupus 1995;4:232-5.
74. Mantz FA, Craige E. Portal axis thrombosis with spontaneous portacaval shunt and resultant cor pulmonale. AMA Arch Pathol 1951;52:91-7.
75. Nakamura H, Uehara H, Okada T, Kambe H, Kimura Y, Ito H, et al. Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant and anti-cardiolipin antibody. Hepatogastroenterology 1989;36:393-7.
76. Morio S, Oh H, Hirasawa A, Aotsuka N, Nakamura H, Asai T, et al. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 8:147-9.
77. Perez Ruiz F, Orte Martinez FJ, Zea Mendoza AC, Ruiz del Arbol L, Moreno-Caparros A. Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature. Semin Arthritis Rheum 1991;21:47-54.
78. Morlà RM, Ramos-Casals M, García-Carrasco M, Cervera R, Font J, Bruguera M, et al. Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature. Lupus 1999;8:160-3.
79. Kesler A, Pomeranz IS, Huberman M, Novis B, Kott E. Cerebral venous thrombosis and chronic active hepatitis as part of the antiphospholipid antibody syndrome. Postgrad Med J 1996;72:690-2.
80. Dourakis SP, Michael AE, Papanikolaou IS, Nomikou E, Thalassinou P, Hadziyannis SJ. Autoimmune hepatitis associated with the antiphospholipid syndrome. Eur J Gastroenterol Hepatol 2001;13:591-3.
81. Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23:199-204.
82. Muñoz-Rodríguez FJ, Tàssies D, Font J, Reverter JC, Cervera R, Sánchez-Tapias JM, et al. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol 1999;30:770-3.
83. Alric L, Oskman F, Sanmarco M, Izopet J, Bonnet E, Garcia-Ricart F, et al. Association of antiphospholipid syndrome and chronic hepatitis C. Br J Rheumatol 1998;37:589-90.
84. Chedid A, Chadalawada KR, Morgan TR, Moritz TE, Mendenhall CL, Hammond JB, et al. Phospholipid antibodies in alcoholic liver disease. Hepatology 1994; 20:1465-71.
85. Violi F, Ferro D, Basili S, D'Angelo A, Mazzola G, Quintarelli C, et al. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. BMJ 1994;309:239-40.
86. Atanassova PA, Panchovska MS, Tzvetanov P, Chalakova NT, Masaldzhieva RI, Dimitrov BD. Hepatolenticular degeneration combined with primary antiphospholipid syndrome: a case report. Eur Neurol 2006;55:42-3.
87. Cappell MS. Eesophageal necrosis and perforation associated with the anticardiolipin antibody syndrome. Am J Gastroenterol 1994;89:1241-5.
88. Kalman DR, Khan A, Romain PL, Nompleggi DJ. Giant gastric ulceration associated with antiphospholipid antibody syndrome. Am J Gastroenterol 1996;91:1244-7.
89. Sánchez-Guerrero J, Reyes E, Alarcón-Segovia D. Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol 1992;19:623-5.
90. Vahl AC, Gans RO, Mackaay AJ, van der Waal C, Rauwerda JA. Superior mesenteric artery occlusion and peripheral emboli caused by an aortic ulcer in a young patient with antiphospholipid syndrome. Surgery 1997; 121:588-90.
91. Cappell MS, Mikhail N, Gujral N. Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies. Dig Dis Sci 1994;39:1359-64.
92. Gül A, Inanç M, Ocal L, Koniçe M, Aral 0, Lie JT. Primary antiphospholipid syndrome associated with mesenteric inflammatory veno-occlusive disease. CIin Rheumatol 1996;15:207-10.
93. North JP, Wollenman OJ. Venous mesenteric occlusion in the course of migratory thrombophlebitis. Surg Gynecol Obstet 1952;95:665-7.
94. Souto JC, Borrell M, Fontcuberta J, Roca M. Antiphospholipid antibodies in inflammatory bowel disease. Dig Dis Sci 1995;40:1524-5.
95. Chang KY, Kuo YC, Chiu CT, Wu SS, Huang CY, Wu CS, et al. Anti-cardiolipin antibody associated with acute hemorrhagic pancreatitis. Pancreas 1993;8:654-7.
96. Date K, Shirai Y, Hatakeyama K. Antiphospholipid antibody syndrome presenting as acute acalculous cholecystitis. Am J Gastroenterol 1997;92:2127-8.
97. Arnold MH, Schrieber L. Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodies. Clin Rheumatol 1988;7:406-10.
98. Pettersson T, Julkunen H. Asplenia in a patient with systemic lupus erythematosus and antiphospholipid antibodies. J Rheumatol 1992;19:1159.
99. Goómez-Puerta JA, Cervera R. Espinosa G, Aguiló S, Bucciarelli S, Ramos-Casals M, et al. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 2006;35:322-32.
100. Ruiz-Irastorza G, Khamashta MA, Hughes GR. Hughes syndrome crosses boundaries. Autoimmun Rev 2002;1:43-8.
101. Alarcon Segovia D, Osmundson PJ. Peripheral vascular syndromes associated with systemic lupus erythematosus. Ann Intern Med 1965;62:907-19.
102. Bird AG, Lendrum R, Asherson RA, Hughes GR. Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaermic necrosis of extremities. Ann Rheum Dis 1987;46:251-5.
103. Asherson RA, Derksen RH, Harris EN, Bingley PJ, Hoffbrand BI, Gharavi AE, et al. Large vessel occlusion. and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases. J Rheumatol, 1986;13:740-7.
104. Ferrante FM, Myerson GE, Goldman JA. Subclavian artery thrombosis mimicking the aortic arch syndrome in systemic lupus erythematosus. Arthritis Rheum 1982;25:1501-4.
105. Asherson RA, Harris EN, Gharavi AE, Englert HE, Hughes GR. Aortic arch syndrome associated with anticardiolipin antibodies and the lupus anticoagulant: comment on Ferrante paper. Arthritis Rheum 1985; 28:594-5.
106. Asherson RA, Ridley MG, Khamashta MA, Hughes GR. Gangrena en el lupus eritematoso sistemico. Piel 1988;3:409-12.
107. Drew P, Asherson RA, Zuk RJ, Goodwin FJ, Hughes GR. Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies. Ann Rheum Dis 1987;46:612-6.
108. Ter Borg EJ, Van der Meer J, De Wolf JT, Van Leeuwen MH, Kallenberg CG. Arterial thrombotic manifestations in young women associated with the lupus anticoagulant. Clin Rheumatol 1988;7:74-9.
109. Hughes GR. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J (Clin Res Ed) 1983;287:1088-9.
110. Khamashta MA, Gil A, Anciones B, Lavilla P, Valencia ME, Pintado-V, et al. Chorea. in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 1988;47:681-3.
111. Asherson RA, Derksen RH, Harris EN, Bouma BN, Gharavi AE, Kater L, et al. Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies. Semin Arthritis Rheum 1987,16:253-9.
112. Sun KH, Liu WT, Tsai CY Iiao TS, Lin WM, Yu CL. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serun. Ann Rheum Dis 1992:51:707-12.
113. Khalili A, Cooper RC. A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1991; 85.365-72.
114. Oosting JD, Derksen RH, Blokzijl, L, Sixma JJ, de Groot PG. Antiphespholipid antibody positive sera enhance endothelial cell procoagulant activity - studies in a thrombosis model. Thromb Haemost 1992,68:278-4.
115. Simantov R, LaSala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995;96:2211-9.
116. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with eridothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997;40:551-61.
117. Pierangeli SS, Harris EN. In vivo models of thrombosis for the antiphospholipid syndrome. Lupus 1996;5:451-5.
118. Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest 1997;100:613-9.
119. Blank M, Krause L, Fridkin M, Keller N, Kopolovic J, Goldberg I, et al. Bacterial induction of autoandbodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002;109:797-804.
120. Shah NM, Khamashta MA, Atsumi T, Hughes GR. Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus 1998;7:3-6.
121. Hilker R, Thiel A, Geisen C, Rudolf J. Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome. Lupus 2000;9:311-6.
122. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GR. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984;2:47-51.
123. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematopus,, lupus-ike disease, and the primary antiphospholipid syndrome. Am J Med 1989;86:391-9.
124. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-4.
125. Kushner M, Simonian N. Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia. Stroke 1989;20:225-9.
126. Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ, et al. IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke 1997;28:1660-5.
127. Provenzale JM, Barboriak DP, Allen NB, Ortel TL. Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR Am J Roentgenol 1996;167: 1573-8.
128. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 1988;23:380-4.
129. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541-4.
130. Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000;79:57-68.
131. Levine SR, Langer SL, Albers JW, Welch KM. Sneddon's syndrome: an antiphospholipid antibody syndrorne? Neurology 1988;38:798-800.
132. Kalashnikova LA, Nasonov EL, Kushekbaeva AE, Gracheva LA. Anticardiolipin antibodies in Sneddon's syndrome. Neurology 1990;40:464-7.
133. Menzel C, Reinhold U, Grünwald F, von Smekal A, Uerlich M, Rieker O, et al. Cerebral blood flow in Sneddon syndrome. J Nucl Med 1994;35:461-4.
134. Sneddon IB. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 1965;77:180-5.
135. Brey RL, Escalante A, Futrell N, Asherson RA. Cerebral thrombosis and other neurologic manifestations in the Antiphospholipid. Syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, editors. The Antiphospholipid Syndrome. 1th ed. Boca Raton, FL: CRC-Press; 1996. p.133-50.
136. Stockhammer G, Felber SR, Zelger B, Sepp N, Birbamer GG, Fritsch PO, et al. Sneddon's Syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke 1993;24:685-90.
137. Tuhrim S, Rand JH, Wu XX, Weinberger J, Horowitz DR, Goldman ME, et al. Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke 1999;30:1561-5.
138. Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283-8.
139. Metz LM, Edworthy S, Mydlarski R, Fritzler MJ. The frequency of phospholipid antibodies in an unselected stroke population. Can J Neurol Sci 1998;25:64-9.
140. Tuhrim S, Rand JH, Wu X, Horowitz DR, Weinberger J, Goldman ME, et al. Antiphosphatidyl serine anti-bodies are independently associated with ischemic stroke. Neurology 1999;53:1523-7.
141. Gómez-Pacheco L, Villa AR, Drenkard C, Cabiedes J, Cabral AR, Alarcón-Segovia D. Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients. Am J Med 1999;106:417-23.
142. Levine SR, Brey RL, Sawaya KL, Salowich-Palm L, Kokkinos J, Kostrzema B, et al. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 1995;38:119-24.
143. Heinzlef O, Abuaf N, Cohen A, Amarenco P.; French Study of Aortic Plagues in Stroke Group. Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study. J Neurol 2001;248:373-9.
144. Briley DP, Coull BM, Goodnight SH. Neurological disease associated with antiphospholipid antibodies. Ann Neurol 1989;25:221-7.
145. Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis?a review of 38 cases. Stroke 1985; 16:199-213.
146. Montón F, Rebollo M, Quintana F, Berciano J. Cerebral arterial occlusion and intracranial venous thrombosis in a woman taking oral contraceptives. Postgrad Med J 1984;60:426-8.
147. Montalbán J, Arboix A, Staub H, Barquinero J, Martí-Vilalta J, Codina A, et al. Transient global amnesia and antiphospholipid antibodies. Clin Exp Rheumatol 1989;7:85-7.
148. Brey RL, Gharavi AE, Lockshin MD. Neurologic complications of antiphospholipid antibodies. Rheum Dis Clin North Am 1993;19:833-50.
149. Montalbán J, Cervera R, Font J, Ordi J, Vianna J, Haga HJ, et al. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology 1992;42:681-2.
150. Sanna G, Cuadrado MJ, Nurchis P, Khamashta MA, Mathieu A, Hughes GRV. Prevalence of headache and relationship with the presence of antiphospholipid antibodies in patients with systemic lupus erythematosus. J Autoimmun 2000;15:P177 (A75).
151. Lau SO, Bock GH, Edson JR, Michael AF. Sagittal sinus thrombosis in the nephrotic syndrome. J Pediatr 1980;97:948-50.
152. Khoo KB, Long FL, Tuck RR, Allen RJ, Tymms KE. Cerebral venous sinus thrombosis associated with the primary antiphospholipid syndrome. Resolution with local thrombolytic therapy. Med J Aust 1995;162:30-2.
153. Mackworth-Young CG, Hughes, GR. Epilepsy: an early symptom of systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1985;48:185.
154. Inzelberg R, Korczyn AD. Lupus anticoagulant and late onset seizures. Acta Neurol Scand 1989;79:114-8.
155. Cocito L, Favale E, Reni L. Epileptic seizures in cerebral arterial occlusive disease. Stroke 1982;13:189-95.
156. Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GR. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:568-71.
157. Liou HH, Wang CR, Chen CJ, Chen RC, Chuang CY, Chiang IP, et al. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus 1996; 5:307-12.
158. Sabet A, Sibbitt WL, Stidley CA, Danska J, Brooks WM. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 1998;29:2254-60.
159. Angelini L, Granata F, Zibordi F, Binelli S, Zorzi G, Besana C. Partial seizures associated with antiphospholipid antibodies in childhood. Neuropediatrics 1998;29:249-53.
160. Verrot D, San-Marco M, Dravet C, Genton P, Disdier P, Bolla G, et al. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am J Med 1997;103:33-7.
161. Peltola JT, Haapala A, Isojärvi JI, Auvinen A, Palmio J, Latvala K, et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med 2000;109:712-7.
162. Liou HH, Wang CR, Chou HC, Arvanov VL, Chen RC, Chang YC, et al. Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons. Life Sci 1994;54:1119-25.
163. Kent MN, Alvarez FJ, Ng AK Rote NS. Ultrastructural localization of monoclonal antiphospholipid. antibody binding to rat brain. Exp Neurol 2000;163:173-9.
164. Wiechens B, Schroder JO, Pötzsch B, Rochels R. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol 1997;123:848-50.
165. Gibbs AN, Moroney J, Foley-Nolan D, O'Connell PG. Neuromyelitis optica. (Devic's syndrome) in systemic lupus erythematosus: a case report. Rheumatology (Oxford) 2002;41:470-1.
166. Reino S, Muñoz-Rodriguez FJ, Cervera R, Espinosa G, Font J, Ingelmo M. Optic neuropathy in the "primary" antiphospholipid. syndrome: report of a care and review of the literature. Clin Rheumatol 1997;16:629-31.
167. Montehermoso A. Cervera R, Font J, Ramos-Casals M, García-carrasco M, Formiga F, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum 1999;28:326-32.
168. Giorgi D, Gabrieli CB, Bonomo L. The clinico-ophthalmological spectrum of antiphospholipid syndrome. Ocul Immunol Inflamm 1998;6:269-73.
169. Labutta RJ. Ophthalmic manifestations in the antiphospholipid syndrome. In: The Antiphospholipid Syndrome. Asherson R, A, Cervera R, Piette J-C, Shoenfeld Y., (editors). Boca Raton, New York, London, Tokyo: CRC Press; 1996. p.213-8.
170. Navarrete MG, Brey RL, Levine SR. Cerebral disease in the antiphospholipid syndrome. In: Khamashta MA, editor. Hughes' syndrome. London: Springer, 2000. p.43-58.
171. Mikdashi J A, Chase C, Kay GG. Neurocognitive deficits in antiphospholipid syndrome. Neurology 1996;46:A359.
172. Westerman EM, Miles JM, Backonja M, Sundstrom WR. Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event. Arthritis Rheum 1992;35:1038-41.
173. Mosek A, Yust I, Treves TA, Vardinon N, Korczyn AD, Chapman J. Dementia and antiphospholipid antibodies. Dement Geriatr Cogn Disord 2000;11:36-8.
174. Fernando SJ. An attack of chorea complicating oral contraceptive therapy. Practitioner 1966;197:210-1.
175. Asherson RA, Hughes GR. Antiphospholipid antibodies and chorea. J Rheumatol 1988;15:377-9.
176. Sundén-Cullberg J, Tedroff J, Aquilonius SM. Reversible chorea in primary antiphospholipid syndrome. Mov Disord 1998;13:147-9.
177. Tam LS, Cohen MG, Li EK. Hemiballismus in systemic lupus erythematosus: possible association with antiphospholipid antibodies. Lupus 1995;4:67-9.
178. Singh RR, Prasad K, Kumar A, Misra A, Padmakumar K, Malaviya AN. Cerebellar ataxia in systemic lupus erythematosus: Three case reports. Ann Rheum Dis 1988;97:954-6.
179. Milanov I, Bogdanova D. Antiphospholipid syndrome and dystonia-parkinsonism. A case report. Parkinsonism Relat Discord 2001;7:139-41.
180. Kurtz G, Müller N. The antiphospholipid syndrome and psychosis. Am J Psychiatry 1994;151:1841-2.
181. Sirota P, Schild K, Firer M, et al. The diversity of autoantibodies in schizophrenic patients and their first degree relatives: analysis of multiple case families. In: Abstracts. First International Congress of the International Society of Neuro-Immune Modulation. Florence, ISNIM; 1991. p. 389.
182. Maes M, Meltzer H, Jacobs J, Suy E, Calabrese J, Minner B, et al. Autoimmunity in depression: increased antiphospholipid autoantibodies. Acta Psychiatr Scand 1993;87:160-6.
183. Karussis D, Leker RR, Ashkenazi A, Abramsky O. A subgroup of multiple sclerosis patients with anticar-diolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998;44:629-34.
184. Ruiz-Irastorza G, Khamashta MA. Warfarin for multiple sclerosis? QJM 2000;93:497-9.
185. Marullo S, Clauvel JP, Intrator L, Danon F, Brouet JC, Oksenhendler E. Lupoid sclerosis with antiphospholipid and antimyelin antibodies. J Rheumatol 1993;20:747-9.
186. Hughes GR. The antiphospholipid syndrome and 'multiple sclerosis'. Lupus 1999;8:89.
187. Scott TF, Hess D, Brillman J. Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by CNS involvement in the antiphospholipid syndrome magnetic resonance imagmg. Arch Intern Med 1994;154:917-20.
188. Tourbah A, Clapin A, Gout O, Fontaine B, Liblau R, Batteux F, et al. Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study. Arch Neurol 1998;55:517-21.
189. Lavalle C, Pizarro S, Drenkard C, Sánchez-Guerrero J, Alarcón-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990; 17:34-7.
190. Ruiz-Argüelles GJ, Guzmán-Ramos J, Flores-Flores J, Garay-Martínez J. Refractory hiccough heralding transverse myelitis in the primary antiphospholipid syndrome. Lupus 1998;7:49-50.
191. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000;59:120-4.
192. Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol 1995;242:326-31.
193. Smyth AE, Bruce IN, McMillan SA, Bell AL. Transverse myelitis: a complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome. Ulster Med J 1996;645:91-4.
194. Oppenheimer S, Hoffbrand BI. Optic neuritis and myelopathy in systemic lupus erythematosus. Can J Neurol Sci 1986;13:129-32.
195. Markusse HN, Haan J, Tan WD, Breedveld FC. Anterior spiral artery syndrome in systemic lupus erythematosus. Br J Rheumatol 1989;28:344-6.
196. Orefice G, De Joanna G, Coppola M, Brancaccio V, Ames PR. Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome? Lupus 1995;4:324-6.
197. Sussman J, Leach M, Greaves M, Malia R, Davies-Jones GA. Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1997;62:229-33.
198. Leker RR, Steiner I. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol 1998;55:817-20.
199. Kesler A, Ellis MH, Reshef T, Kott E, Gadoth N. Idiopathic intracranial hypertension and anticardiolipin antibodies. J Neurol Neurosurg Psychiatry 2000;68: 379-80.
200. Hisashi K Komune S, Taira T, Uemura T, Sadoshima S, Tsuda H. Anticardiolipin antibody-induced sudden profound sensorineural hearing loss. Am J Otolaryngol 1993;14:275-7.
201. Casoli P, Tumiati B. Cogan's syndrome: a new possible complication of antiphospholipid antibodies? Clin Rheumatol 1995;14:197-8.
202. Toubi E, Ben-David J, Kessel A, Podoshin L, Golan TD. Autoimmune aberration in sudden sensorineural hearing loss: association with anti-cardiolipin antibodies. Lupus 1997;6:540-2.
203. Naarendorp M, Spiera H. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies. J Rheumatol 1998;25:589-92.
204. Gilburd B, Stein M, Tomer Y, Tanne D, Abramski. O, Chapman Y, et al: Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barré syndrome: crow-reactive or pathogenic? Autoimmunity 1993;16:23-7.
205. Ruiz-Irastorza G, Khamashta MA, Hughes GR. Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome. Lupus 2001;10:241-5.
206. Khamashta MA. Management of thrombosis in the antiphospholipid syndrome. In: Khamashta MA, editor. Hughes' syndrome. London: Springer; 2000. p.391-6.
207. Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence in thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Am J Med 1998;104:332-8.
208. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314:253-7.
209. Castellino G, Cuadrado MJ, Godfrey T, Khamashta MA, Hughes GR. Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment. Ann Rheum Dis 2001; 60:527-30.
210. Erkan D. Therapeutic and prognostics consideraitons in catastrophic antiphospholipid syndrome. Autoimmun Rev 2006;6:98-103.
211. Ordonez L, Skromne E, Ontaneda D, Rivera VM. Multiphasic disseminated encephalomyelitis systemic lupus erythematosus and antiphospholipid syndrome. Clin Neurol Neurosurg 2007;109:102-5.